Endocrinoloxía e nutrición
Servicio
Hospital Universitario San Cecilio
Granada, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario San Cecilio (19)
2024
-
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-related cancer
-
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466
-
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
Pituitary, Vol. 27, Núm. 5, pp. 497-506
-
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-Related Cancer, Vol. 31, Núm. 7
2021
-
Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition
Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 4, pp. 270-276
2014
2013
-
Changes in acromegaly treatment over four decades in Spain: Analysis of the Spanish Acromegaly Registry (REA)
Pituitary, Vol. 16, Núm. 1, pp. 115-121
2012
2008
-
Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population
Clinical Endocrinology, Vol. 68, Núm. 6, pp. 942-950
2007
-
Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: A 12-month, double-blind, parallel clinical trial
Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 9, pp. 3446-3452
2006
-
Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial
Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326
-
Orlistat reduce la obesidad abdominal. Un metaanálisis
Revista Espanola de Obesidad, Vol. 4, Núm. 5, pp. 295-300
2004
-
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA)
European Journal of Endocrinology, Vol. 151, Núm. 4, pp. 439-446
2003
-
Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage
Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481
2002
-
A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test
Clinical Endocrinology, Vol. 57, Núm. 3, pp. 377-384
-
Diagnóstico del déficit de hormona del crecimiento en pacientes adultos
Endocrinologia y Nutricion
-
Eficacia y seguridad del sildenafilo en varones con diabetes mellitus tipo 2 y disfunción eréctil
Medicina Clinica, Vol. 119, Núm. 4, pp. 121-124
-
Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses
Neuroendocrinology, Vol. 76, Núm. 6, pp. 390-396
2000
-
GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults
Lancet, Vol. 356, Núm. 9236, pp. 1137-1142